Completed
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
NCT00616928
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Huntsville, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Anaheim, California, United States
- GSK Investigational Site Jacksonville, Florida, United States